Hemoglobinopathies

Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

A Clinical Exploratory Study of YOLT-204 in the Treatment of Hemoglobinopathies

A Long-term Follow-up Study in Participants Who Received CTX001

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Allo HSCT for High Risk Hemoglobinopathies

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Discarded Bone Marrow for Hematology Research

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

A Blood Stem Cell Transplant for Sickle Cell Disease

Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh

A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion